Fewer than half of employer plans cover weight-loss drugs Wegovy and Ozempic are glucagon-like peptide-1 drugs, or GLP-1s, that suppress the appetite of users, leading to weight loss
After the initial period, its dosage may be increased to 20 mcg once daily if additional glycemic control is needed
This phenomenon is particularly notable for patients taking extended-release formulations
Funding This work was supported by the Basque Government (IT1620-22)
Critical quality attributes for biologic APIs include protein primary sequence (confirmed by peptide mapping), glycosylation profile (N-glycan site occupancy and glycoform distribution), aggregation level (high molecular weight species by size exclusion chromatography), charge variant distribution (by ion exchange chromatography or capillary isoelectric focusing), potency (by cell-based bioassay), and host cell protein (HCP) content
P, 68 years old, was diagnosed with Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrigs Disease) five years ago